Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
New Approaches to the Diagnosis, Clinical Course, and Goals of Therapy in Multiple Sclerosis and Related Disorders.
NG2-glia, More Than Progenitor Cells.
Peripheral Vasculitis, Intermediate Uveitis and Interferon Use in Multiple Sclerosis.
Lithium Restores Age Related Olfactory Impairment in the Ts65Dn Mouse Model of Down Syndrome.
Multiple sclerosis : understanding a complex neurological condition.
Functional MRI in investigating cognitive impairment in multiple sclerosis.
Neuroimaging findings of Zika virus infection: a review article.
A lesion topography-based approach to predict the outcomes of patients with multiple sclerosis treated with Interferon Beta.
A Microsoft Kinect-Based Point-of-Care Gait Assessment Framework for Multiple Sclerosis Patients.
MRI differential diagnosis of suspected multiple sclerosis.
Identification of Tricyclic Agonists of Sphingosine-1-Phosphate Receptor 1 (S1P1) Employing Ligand-Based Drug Design.
Brain Atrophy as a Measure of Neuroprotective Drug Effects in Multiple Sclerosis: Influence of Inflammation.
Myeloid cells - targets of medication in multiple sclerosis.
Impact on the Incremental Cost-Effectiveness Ratio of Using Alternatives to EQ-5D in a Markov Model for Multiple Sclerosis.
Ex vivo expanded regulatory T cells CD4(+)CD25(+)FoxP3(+)CD127(Low) develop strong immunosuppressive activity in patients with remitting-relapsing multiple sclerosis.
Acute Disseminated Encephalomyelitis in an Incarcerated Adolescent Presents as Acute Psychosis: Case Report and Literature Review.
Intravenous Methylprednisolone-Induced Nocturnal Sinus Bradycardia in a Multiple Sclerosis Patient.
Adaptive vs. non-adaptive cognitive training by means of a personalized App: a randomized trial in people with multiple sclerosis.
Significant Contribution of Mouse Mast Cell Protease 4 in Early Phases of Experimental Autoimmune Encephalomyelitis.
Peptidyl Arginine Deiminases and Neurodegenerative Diseases.
Role of Therapeutic Plasma Exchange in Treatment of Tumefactive Multiple Sclerosis-Associated Low CD4 and CD8 Levels.
Health Utilities for Multiple Sclerosis.
The Impact of the Nurses' Health Study on Population Health: Prevention, Translation, and Control.
Remyelination Is Correlated with Regulatory T Cell Induction Following Human Embryoid Body-Derived Neural Precursor Cell Transplantation in a Viral Model of Multiple Sclerosis.
Fingolimod: A Disease-Modifier Drug in a Mouse Model of Amyotrophic Lateral Sclerosis.
Pages
« first
‹ previous
…
744
745
746
747
748
749
750
751
752
…
next ›
last »